Inside Incyte’s $120 Million AI For Drug Development Deal
- Posted on May 20, 2026
- By Forbes
- 0 Views
- 1 min read
Inside Incyte’s $120 Million AI For Drug Development Deal
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, nd more.
